Is Aristo Bio-Tech overvalued or undervalued?

Sep 18 2025 08:08 AM IST
share
Share Via
As of September 17, 2025, Aristo Bio-Tech is considered expensive and overvalued with a PE Ratio of 23.31, despite outperforming the Sensex with a 30.95% return, as it trades at a premium compared to its earnings growth potential and is more expensive than some peers like Sharda Cropchem.
As of 17 September 2025, the valuation grade for Aristo Bio-Tech has moved from very expensive to expensive. The company is currently considered overvalued based on its financial ratios and peer comparisons. Key ratios include a PE Ratio of 23.31, an EV to EBITDA of 12.45, and a PEG Ratio of 5.68, which suggest that the stock is trading at a premium compared to its earnings growth potential.

In comparison to its peers, Aristo Bio-Tech's PE Ratio of 23.31 is significantly lower than UPL's 39.58, indicating that while Aristo is expensive, it is not as overvalued as some of its competitors. However, it is still higher than Sharda Cropchem's PE of 19.35, which is considered attractive. Notably, Aristo Bio-Tech's recent stock performance has outpaced the Sensex, with a 1-year return of 30.95% compared to a decline of 0.35% in the Sensex, reinforcing the notion of its overvaluation amidst a strong market performance.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Aristo Bio-Tech falling/rising?
Nov 22 2025 01:28 AM IST
share
Share Via
How has been the historical performance of Aristo Bio-Tech?
Nov 15 2025 12:27 AM IST
share
Share Via
Why is Aristo Bio-Tech falling/rising?
Oct 29 2025 01:57 AM IST
share
Share Via
Why is Aristo Bio-Tech falling/rising?
Sep 30 2025 11:29 PM IST
share
Share Via
Why is Aristo Bio-Tech falling/rising?
Sep 29 2025 11:38 PM IST
share
Share Via
Why is Aristo Bio-Tech falling/rising?
Sep 24 2025 11:32 PM IST
share
Share Via
Is Aristo Bio-Tech overvalued or undervalued?
Sep 24 2025 08:08 AM IST
share
Share Via
Most Read
Why is Vikram Aroma falling/rising?
3 hours ago
share
Share Via
Why is Solarium Green falling/rising?
3 hours ago
share
Share Via
Why is Unimech Aero. falling/rising?
3 hours ago
share
Share Via
Why is Transrail Light falling/rising?
3 hours ago
share
Share Via
Why is Unilex Colour &C falling/rising?
3 hours ago
share
Share Via
Why is Dindigul Farm falling/rising?
3 hours ago
share
Share Via
Why is GP Eco Solutions falling/rising?
3 hours ago
share
Share Via